<i>Trypanosoma cruzi</i> Reactivation After Chimeric Antigen Receptor T-Cell Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trypanosoma cruzi Reactivation After Chimeric Antigen Receptor T-Cell Therapy

Published:2024-01 Issue:1 Volume:11 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Alahmdi Bayan¹^ORCID,Kaur Avneet²,Jacobs Samantha E³,Sullivan Timothy³^ORCID,Barghash Maya⁴,Taimur Sarah³^ORCID

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, King Abdulaziz University , Jeddah , Saudi Arabia

2. Division of Infectious Diseases, Department of Medicine, City of Hope , Duarte, California , USA

3. Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai , New York, New York , USA

4. Division of Cardiology, Icahn School of Medicine at Mount Sinai , New York, New York , USA

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ofid/article-pdf/11/1/ofad698/56549365/ofad698.pdf

Reference22 articles.

1. Reactivation of Chagas disease among heart transplant recipients in the United States, 2012–2016;Gray;Transpl Infect Dis,2018

2. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: a review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections;Fabiani;Transpl Infect Dis,2017

3. Reactivation of Chagas disease in a bone marrow transplant patient: case report and review of screening and management;Guiang;Transpl Infect Dis,2013

4. Reactivation of Chagas’ disease in a patient with non-Hodgkin's lymphoma: gastric, oesophageal and laryngeal involvement;Rezende;Trans R Soc Trop Med Hyg,2006

5. Reactivation of Chagas’ disease during therapy of acute lymphocytic leukemia;Kohl;Cancer,1982

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastics;Reactions Weekly;2024-04-06

2. Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment;Open Forum Infectious Diseases;2023-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3